Format

Send to

Choose Destination
Haematologica. 2018 Apr;103(4):e158-e161. doi: 10.3324/haematol.2017.182634. Epub 2017 Dec 21.

No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy.

Author information

1
Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
2
Department of Hematology, Uppsala University Hospital, Sweden.
3
Institute of Applied Biosciences, Thessaloniki, Greece.
4
Università Vita-Salute San Raffaele, Milan, Italy.
5
Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
6
Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
7
The Feinstein Institute for Medical Research, Northwell Health, New York, USA.
8
CEITEC-Central European Institute of Technology, MasarykBrno, Czech Republic.
9
University Hospital Brno, Czech Republic.
10
Department of Immunology, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
11
Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
12
First Department of Propaedeutic Medicine, University of Athens, Greece.
13
Molecular Pathology Unit and Haematology Department, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy.
14
Department of Medicine Solna, Clinical Epidemiology Unit, Karolinska Institutet, and Hematology Center, Karolinska University Hospital, Stockholm, Sweden.
15
IMGT®, the international ImMunoGeneTics information system®, Université de Montpellier, Laboratoire d'ImmunoGénétique Moléculaire LIGM, Institut de Génétique Humaine IGH, UPR CNRS 1142, Montpellier, France.
16
Hematology Department and University Pierre et Marie Curie, Hopital Pitie-Salpetriere, Paris, France.
17
Lund University and Hospital Department of Hematology, Lund Stem Cell Center, Sweden.
18
Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
19
Department of Medicine, Hematology and Clinical Immunology Branch, Padova University School of Medicine, Italy.
20
Venetian Institute of Molecular Medicine, Padova, Italy.
21
Department of Hemato-Oncology, Belfast City Hospital, Belfast, UK.
22
Department of Immunology, Mayo Clinic, Rochester, MV, USA.
23
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
24
Hematology Department, Nikea General Hospital, Piraeus, Greece.
25
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
26
Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden kostas.stamatopoulos@gmail.com.

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center